Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Contamination Issues Drove Drug Recalls to Record Levels in 2011

Mar 28 2012

• By Bowman Cox

Related Content

Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters

Mar 01 2011

Glass Quality Crisis Prompts Multi-Faceted Array of Risk-Based Improvements

Aug 01 2011

Another Busy Year of Drug Recalls Led to Shortages of Injectables

May 01 2011

FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations

Feb 21 2012

APP Pharmaceuticals, Praised For Easing Drug Shortages, Gets Manufacturing Warning Letter

Mar 05 2012

Advantage Dose's GMP Issues Mirrored Earlier Problems Affecting Repackers

May 01 2010

Using Third-Party Repackagers Improves Hospital Patient Safety, Experts Say

May 01 2010

Record Drug Recall Totals for 2009 Resulted from GMP Breakdowns

May 01 2010

Data Integrity Problems Continued to Surface in Recent Warning Letters

Feb 01 2010

McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs

Jan 18 2010

<em>Lipitor</em> Goes Generic, But First-Filer Ranbaxy’s Approval Leaves Plenty Of Questions In Its Wake

Dec 05 2011

Related Companies

GSK plc

EKR Therapeutics Inc.

Allergan plc

Sanofi

Abbott

Amgen, Inc.

AstraZeneca PLC

Novo Nordisk A/S

Johnson & Johnson

Fresenius SE & Co. KGaA

Hospira, Inc.

Teva Pharmaceutical Industries Ltd.

Perrigo Company PLC

Bristol Myers Squibb Company

Dr. Reddy's Laboratories Ltd.

Johnson & Johnson

Johnson & Johnson

Pfizer Inc.

Baxter International Inc.

Bausch Health Companies Inc.

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window